Premium Nahrungsergänzungsmittel | artgerecht

Dermatitis Markers – Biomarkers in Skin Inflammation

Dermatitis markers are laboratory values and biological parameters used to diagnose and monitor the progression of dermatitis.

Regular tips about health Regular tips about health

Things worth knowing about "Dermatitis Markers"

Dermatitis markers are laboratory values and biological parameters used to diagnose and monitor the progression of dermatitis.

What Are Dermatitis Markers?

Dermatitis markers are biological measurements (biomarkers) that can be detected in the blood, tissue, or on the skin surface. They provide important information about the presence, severity, and progression of dermatitis (skin inflammation). These markers help physicians confirm diagnoses, monitor disease activity, and assess responses to treatments.

Types of Dermatitis and Their Markers

Atopic Dermatitis (Eczema)

Atopic dermatitis is a chronic inflammatory skin condition with a strong genetic component. Key biomarkers include:

Total IgE: Elevated immunoglobulin E levels in the blood indicate allergic sensitization.
Specific IgE: Detection of antibodies against particular allergens (e.g., dust mites, food proteins).
TARC/CCL17 (Thymus and Activation Regulated Chemokine): A cytokine that is significantly elevated during active atopic dermatitis and serves as a sensitive marker for disease severity.
Eosinophils: Elevated eosinophil counts in the blood differential are indicative of allergic inflammatory processes.
IL-4, IL-13, IL-31: Interleukins that play central roles in type 2 immune responses and are elevated in atopic dermatitis.
Periostin: A protein released during type 2 inflammation that correlates with atopic dermatitis severity.

Contact Dermatitis

In allergic contact dermatitis, specific blood markers are less prominent. Diagnosis is primarily clinical and confirmed by the patch test (epicutaneous test). Histological markers from skin biopsies typically show a lymphocytic infiltrate.

Seborrheic Dermatitis

No specific blood markers are established for seborrheic dermatitis. Diagnosis is made clinically. However, research studies investigate markers related to fungal colonization (particularly Malassezia species) and local inflammatory responses.

Clinical Importance of Dermatitis Markers

Dermatitis markers have taken on an increasingly important role in modern dermatology:

Diagnostic support: Differentiation between various forms of dermatitis and distinction from other skin conditions.
Disease severity assessment: Markers such as TARC/CCL17 and total IgE correlate well with the clinical severity of atopic dermatitis.
Therapy monitoring: Declining levels of markers such as TARC or IL-13 during biologic therapy (e.g., dupilumab) indicate a positive treatment response.
Prediction: Certain markers can help predict the risk of disease flares or complications.

Diagnosis and Laboratory Testing

Dermatitis markers are assessed as part of a comprehensive diagnostic workup. Common investigations include:

Full blood count with differential (eosinophil percentage)
Serum IgE (total and specific)
Cytokine panels (IL-4, IL-13, IL-31, TARC) in specialized laboratories
Skin biopsy with histological and immunohistochemical analysis
Patch test when contact allergy is suspected

Therapeutic Relevance

Knowledge of specific dermatitis markers has enabled the development of targeted therapies. Modern biologics such as dupilumab selectively block IL-4 and IL-13 signaling pathways and have transformed the treatment of moderate-to-severe atopic dermatitis. Elevated marker levels help identify suitable candidates for such therapies.

References

Wollenberg, A. et al. - European guideline (EuroGuiDerm) on atopic eczema. Journal of the European Academy of Dermatology and Venereology, 2022.
Egawa, G. & Kabashima, K. - Multifactorial skin barrier deficiency and atopic dermatitis. Journal of Allergy and Clinical Immunology, 2016.
Werfel, T. et al. - S2k guidelines on atopic dermatitis. AWMF Register No. 013-027, 2023.

Building Blocks for a Healthy Life

As an integrated manufacturer, we develop & produce evidence-based, patented, and non-patented formulations. We work exclusively with plant and natural extracts according to the strictest purity & quality standards.
The combination of science & modern technology with the laws of nature creates solutions consistently tailored to humans – for the highest good: health.